Tag: LUTRATE
Sayre Therapeutics to market oncology product of Spain’s GP Pharm
Spanish firm, GP Pharm will supply the prostate cancer drug, LUTRATE® to Bangalore-based Sayre Therapeutics on an exclusive basis from its manufacturing facility in Barcelona.........